Table 1. Criteria for robust evidence regarding LP and access

Criteria	Explanation
Study objective	Define the relationship between LP and 'access' to biomedical products (medicines and/or diagnostics)
Study design	Interrupted time series analysis, and/or Repeated measures studies, and/or Controlled or uncontrolled before (-LP) and after (+LP) studies and/or One-time descriptive comparisons of local and foreignmade products.
Study sites	Low and middle income countries Public and/or private health care institutions and/or pharmaceutical retail sector and/or public or private biomedical manufacturing site(s)
Preferred Study outcomes	Demonstrating a causal or strongly inferential link between LP of a medical product and improved/modified/ enhanced access to that product